Table 1.
Acaricide | Trial date | Dose (ppm) | Control mortality (%) | Corrected mortality (%) |
---|---|---|---|---|
Fluralaner | 3-Apr-15 | 0 | 11.90 | |
1 | 2.94 | |||
2 | 34.98 | |||
5 | 83.98 | |||
10 | 100.00 | |||
20 | 98.62 | |||
20-Mar-15 | 0 | 5.60 | ||
1 | 40.52 | |||
2 | 41.04 | |||
5 | 92.86 | |||
10 | 100.00 | |||
20 | 100.00 | |||
8-Mar-15 | 0 | 12.10 | ||
1 | 0.00a | |||
2 | 29.58 | |||
5 | 81.04 | |||
10 | 100.00 | |||
20 | 100.00 | |||
Trial Average | 1 | 14.48 | ||
2 | 35.20 | |||
5 | 82.02 | |||
10 | 100.00 | |||
20 | 99.54 | |||
Spinosad | 20-Feb-15 | 0 | 15.60 | |
200 | 0.00a | |||
400 | 0.00a | |||
1000 | 25.00 | |||
2000 | 78.29 | |||
4000 | 95.92 | |||
27-Feb-15 | 0 | 18.60 | ||
200 | 0.00a | |||
400 | 0.00a | |||
1000 | 20.83 | |||
2000 | 83.88 | |||
4000 | 100.00 | |||
Trial Average | 200 | 0.00 | ||
400 | 0.00 | |||
1000 | 22.92 | |||
2000 | 81.09 | |||
4000 | 97.96 | |||
Phoxim | 20-Feb-15 | 0 | 15.60 | |
250 | 0.68 | |||
500 | 83.10 | |||
1000 | 96.05 | |||
1500 | 100.00 | |||
27-Feb-15 | 0 | 18.60 | ||
250 | 6.88 | |||
500 | 87.91 | |||
1000 | 100.00 | |||
1500 | 100.00 | |||
2000 | 100.00 | |||
Trial Average | 250 | 3.78 | ||
500 | 85.51 | |||
1000 | 98.03 | |||
1500 | 100.00 | |||
2000 | 100.00 | |||
Propoxur | 20-Feb-15 | 0 | 15.56 | |
31 | 0.00a | |||
63 | 44.70 | |||
125 | 67.22 | |||
250 | 100.00 | |||
500 | 100.00 | |||
27-Feb-15 | 0 | 18.60 | ||
31 | 1.67 | |||
63 | 42.64 | |||
125 | 89.76 | |||
250 | 100.00 | |||
500 | 100.00 | |||
Trial Average | 31 | 0.84 | ||
63 | 43.67 | |||
125 | 78.49 | |||
250 | 100.00 | |||
500 | 100.00 |
Trials were conducted in spring 2015 and used for probit analysis. Control packets indicated by “0 ppm” dose
aTreatments had less mortality than controls and are marked as no mortality